Reference : BPCO et inflammation : mise au point d'un groupe d'experts. Comment traiter l'inflamm...
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/99954
BPCO et inflammation : mise au point d'un groupe d'experts. Comment traiter l'inflammation ?
French
[en] COPD and inflammation: Statement from a French expert group. How to treat inflammation?
Roche, N. [> > > >]
Devillier, P. [> > > >]
Aguilaniu, B. [> > > >]
Escamilla, R. [> > > >]
Wallaert, B. [> > > >]
Burgel, P.-R. [> > > >]
Berger, P. [> > > >]
Brillet, P.-Y. [> > > >]
Chambellan, A. [> > > >]
Chanez, P. [> > > >]
Chaouat, A. [> > > >]
Louis, Renaud mailto [Centre Hospitalier Universitaire de Liège - CHU > > Pneumologie-Allergologie >]
Mal, H. [> > > >]
Marthan, R. [> > > >]
Muir, J*-F [> > > >]
Perez, T. [> > > >]
Similowski, T. [> > > >]
Aubier, M. [> >]
2011
Revue des Maladies Respiratoires
28
4
427-42
Yes (verified by ORBi)
International
0761-8425
1776-2588
France
[en] INTRODUCTION: Management of chronic obstructive pulmonary disease (COPD) has made considerable progress over the last 15 years, with the development of pulmonary rehabilitation, new molecules to facilitate smoking cessation, and several medical treatments. Many therapeutic needs, however, remain to be met. STATE OF THE ART: Several lines of research on inflammation and COPD are promising, and some will probably result in new treatments. These may target specific populations, identified by clinical phenotype or by biomarkers. The forthcoming arrival of iPDE-4s on the market illustrates how knowledge of inflammation and remodeling and of some of the underlying mechanisms finally, after many years' development, has broadened the range of treatments available to help improve patients' daily life and outcomes. PERSPECTIVES AND CONCLUSIONS: The availability of such treatments, however, does not mean that knowledge of the disease in the general population and among healthcare workers can be neglected. Early detection (at a stage when treatment can already be effective) and patient education which promotes therapeutic compliance and lasting lifestyle change need to be developed further.
http://hdl.handle.net/2268/99954
10.1016/j.rmr.2010.08.017
Copyright (c) 2011 SPLF. Published by Elsevier Masson SAS. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
COPD traitement.pdfPublisher postprint640.83 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.